My key takeaways from initial listen: 1) Noted
Post# of 148185
(Total Views: 324)
Posted On: 05/13/2019 4:18:19 PM
My key takeaways from initial listen:
1) Noted GILD failed P2 NASH study
2) NASH study cost is $12,000 and will not impact focus on HIV or cancer
3) Hope to get NASH results back in 8 weeks, typically 4-5 months but requested this study to be expedited
4) No raises announced and they have a funding strategy/plan that will be discussed at upcoming investor meeting
1) Noted GILD failed P2 NASH study
2) NASH study cost is $12,000 and will not impact focus on HIV or cancer
3) Hope to get NASH results back in 8 weeks, typically 4-5 months but requested this study to be expedited
4) No raises announced and they have a funding strategy/plan that will be discussed at upcoming investor meeting
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Please do your own due diligence. All my posts and comments are not to be considered investment advice.
Scroll down for more posts ▼